Microsoft Word - MD&A_E Q1_2561_จัดใหม่ Management Discussion and Analysis: MD&A 1. Company Situation Revenue from the waste treatment business for Q1/2018 slightly increased compare to Q1/2017. The

Company and its subsidiary for Quarter 3 of 2019 ending on 30 September 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical

subsidiary for Quarter 1 of 2020 ending on 31 March 2020 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for the 1st

advisor supervisors failed to exercise due care in reviewing the information thoroughly which may mislead investors into believing the company continued to expand the business capable of generating

, investor, or other market participant. 2.2 A CRA and its employees should use care and professional judgment to maintain and objectivity. 2.3 factors relevant to assessing the creditworthiness of the rated

of both treatment of industrial waste business division and property development business division is 342.4 million Baht compared with same period of year 2016 amounted 378.6 million Baht, decreased

may cause an adverse effect to the credibility of the Thai capital market as a whole; (4) the offering of securities may cause any damage or an unfair treatment to the investors as a whole, or the

) and to the specific investors (Private Placement) for the restructure of the capital, internal working capital, the investment related to the investment project of Wastewater Treatment Plant at Mandalay

shareholders’ rights, unfair treatment toward shareholders or disclosure of information to shareholders and general investors; (2) having any of the following characteristics within one year prior to the filing

beverages continued its growth momentum at 7.3% YoY, and domestic personal care showed 23.7% growth. Overall international business grew 8.7% at constant FX rate. YTD 1H’19, net sales grew 5.0%, contributed